Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway

被引:58
作者
Ye, Jinyan [1 ,2 ]
Guan, Minqiang [3 ]
Lu, Yao [2 ]
Zhang, Dan [2 ]
Li, Chengye [2 ]
Zhou, Caicun [1 ,4 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Changzhou 213000, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Univ, Lab Anim Ctr, Wenzhou 325000, Peoples R China
[4] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Oncol, Shanghai 200433, Peoples R China
关键词
Arbutin; SIRT1; Lipopolysaccharide; Lung injury; NF-KAPPA-B; INFLAMMATION; INVOLVEMENT; ACTIVATION; EXPRESSION; CROSSTALK; SYSTEM;
D O I
10.1016/j.pupt.2018.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main goal of this study was to evaluate the effects of arbutin (AR) on lipopolysaccharide (LPS)-induced lung injury. A lung injury rat model was established by intravenous LPS administration. We found that levels of inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6) in both serum and lung tissue were significant increased after LPS challenge. In addition, pathological conditions were examined in rat lungs, and it was demonstrated that AR-pretreatment reduced LPS-induced malondialdehyde (MDA) levels and increased LPS-induced superoxide dismutase (SOD) activity. Moreover, the expression of sirtuin1 (SIRT1), nuclear erythroid factor 2-related factor 2 (Nrf-2), heme oxygenase-1 (HO-1) as well as the phosphorylation of NF-kappa Bp65 and I kappa B alpha were increased with LPS-induced lung injury, and were significantly restored by AR treatment. Together, our results indicated that SIRT1 is a potential therapeutic target in LPS-induced lung injury, and that AR may be a novel therapeutic in patients with acute lung injury.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
[41]   Alprostadil attenuates LPS-induced cardiomyocyte injury by inhibiting the Wnt5a/JNK/NF-κB pathway [J].
Yu, T. ;
Dong, D. ;
Guan, J. ;
Sun, J. ;
Guo, M. ;
Wang, Q. .
HERZ, 2020, 45 (SUPPL 1) :130-138
[42]   Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway [J].
Hong, Huanwu ;
Lou, Siyue ;
Zheng, Fanli ;
Gao, Hang ;
Wang, Nina ;
Tian, Shasha ;
Huang, Guozheng ;
Zhao, Huajun .
PHYTOMEDICINE, 2022, 101
[43]   Protective effect of olopatadine hydrochloride against LPS-induced acute lung injury: via targeting NF-κB signaling pathway [J].
Kaur, Jaspreet ;
Rana, Priyanka ;
Matta, Tushar ;
Sodhi, Rupinder Kaur ;
Pathania, Khushboo ;
Pawar, Sandip V. ;
Kuhad, Anurag ;
Kondepudi, Kanthi Kiran ;
Kaur, Tanzeer ;
Dhingra, Neelima ;
Sah, Sangeeta Pilkhwal .
INFLAMMOPHARMACOLOGY, 2024, 32 (01) :603-627
[44]   Leocarpinolide B attenuates LPS-induced inflammation on RAW264.7 macrophages by mediating NF-κB and Nrf2 pathways [J].
Linghu, Ke-Gang ;
Ma, Qiu Shuo ;
Zhao, Guan Ding ;
Xiong, Wei ;
Lin, Ligen ;
Zhang, Qing-Wen ;
Bian, Zhaoxiang ;
Wang, Yitao ;
Yu, Hua .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 868
[45]   VA inhibits LPS-induced oxidative stress via modulating Nrf2/NF-κB-signalling pathways in bovine mammary epithelial cells [J].
Shi, Huiyu ;
Guo, Xiaoyu ;
Yan, Sumei ;
Guo, Yongmei ;
Shi, Binlin ;
Zhao, Yanli .
ITALIAN JOURNAL OF ANIMAL SCIENCE, 2019, 18 (01) :1099-1110
[46]   Stevioside attenuates osteoarthritis via regulating Nrf2/HO-1/ NF-ΚB pathway [J].
Wu, Jia ;
Li, Haoliang ;
Hu, Fei ;
Luo, Peng .
JOURNAL OF ORTHOPAEDIC TRANSLATION, 2023, 38 :190-202
[47]   Post-treatment With Irisin Attenuates Acute Kidney Injury in Sepsis Mice Through Anti-Ferroptosis via the SIRT1/Nrf2 Pathway [J].
Qiongyue, Zhang ;
Xin, Yang ;
Meng, Peng ;
Sulin, Mi ;
Yanlin, Wang ;
Xinyi, Li ;
Xuemin, Song .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[48]   Protective Effects of Tyrosol against LPS-Induced Acute Lung Injury via Inhibiting NF-κB and AP-1 Activation and Activating the HO-1/Nrf2 Pathways [J].
Wang, Wen-chen ;
Xia, Yan-min ;
Yang, Bo ;
Su, Xiang-ni ;
Chen, Jia-kuan ;
Li, Wei ;
Jiang, Tao .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (05) :583-593
[49]   Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-κB pathway in LPS-induced acute lung injury [J].
Li, Tie-Jun ;
Zhao, Lian-Li ;
Qiu, Jing ;
Zhang, Hai-Yan ;
Bai, Guo-Xin ;
Chen, Liang .
MOLECULAR MEDICINE REPORTS, 2017, 16 (02) :2225-2232
[50]   Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-?B signaling pathway [J].
Zhu, Yanru ;
Luo, Lifei ;
Zhang, Meng ;
Song, Xinbo ;
Wang, Ping ;
Zhang, Han ;
Zhang, Jingze ;
Liu, Dailin .
JOURNAL OF ETHNOPHARMACOLOGY, 2023, 301